Viewing Gene With Clinical Trials Data

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Report Bug Request Feature
Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol: JAK3
Name: Janus kinase 3
Location: 19p13.11
Locus Group: protein-coding gene
Gene Type: Protein Coding
Locus Type: gene with protein product
ID+ Clinical Trials CompTox DrugMatrix Conditions Design Enrollment Locations Outcomes
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all

Clinical Studies

NCT Number Status Brief Title View
NCT05115344 Study of Flonoltinib Maleate Tablets in the Treatment of Proliferative Bone Marrow Tumors View
NCT04411043 Observatory of Prolymphocytic Leukemia T View
NCT04670757 Safety and Pharmacokinetics of JAKROCK Inhibitor in Healthy Volunteers View
NCT05153343 Safety of Flunotinib Maleate Tablets for the Treatment of Patients With Myeloproliferative View
NCT05861401 Polymorphism of Janus Kinase 1 and 2 JAK 12 in Patients With Alopecia Areata View
NCT06055023 Study of Tolerability Safety and Pharmacokinetics of ZL-82 in Healthy Adult Subjects View
NCT06432738 ZL-82 Double-blind Clinical Trial View
NCT00483756 Study of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant Patients View
NCT01590459 24-week Study With Open Label Extension of VX-509 an Oral JAK3 Inhibitor in Subjects Taking Methotrexate View
NCT01754935 A Magnetic Resonance Imaging Study and Arthroscopic Biopsy Substudy in Subjects With Active Rheumatoid Arthritis Receiving VX-509 an Oral JAK3 Inhibitor View
NCT05374785 Efficacy and Safety Study Comparing CPL409116 to Placebo in Participants with Active Rheumatoid Arthritis View
NCT05713279 Study of Flonoltinib Maleate Tablets in the Treatment of Severe Novel Coronavirus COVID-19 Infection View
NCT03601819 Pacritinib in RelapsedRefractory Lymphoproliferative Disorders View
NCT00001788 Genetic Basis of Primary Immunodeficiencies View
NCT05128058 A Target Occupancy Study With Ritlecitinib View
NCT06201780 Assessment of Serum Levels of Janus Kinase 1 and 2 in Patients With Cholinergic Urticaria View
NCT06531109 Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib View
NCT01052194 A 12-week Study of 4 Doses of VX-509 in Subjects With Active Rheumatoid Arthritis View
NCT00556257 Study Of JAK3 Inhibitor For The Prevention Of Acute Rejection In Kidney Transplant Patients View
NCT06209138 5-fluorouracil for Treatment of Stable Vitiligo View
NCT00263328 Extension Study Of Stage 1 Subjects Of Study A3921009 For The Prevention Of Acute Rejection In Kidney Transplant Patient View
NCT00860496 A Phase I Open-Label Study of the Effects of Tacrolimus and Cyclosporine on CP-690555 in Healthy Volunteers View